950 TOWER LANE, SUITE 1050, FOSTER CITY, CA
Prices $600.0 Million Convertible Senior Notes Offering; Refinances a Portion of 2029 Convertible Notes
Other Events
Annual Report to Security Holders
Amended material disclosure
Reports Fourth Quarter and Year-End 2025 Results and Provides Business Update
Completes Acquisition of Bluejay Therapeutics, Expanding Global Leadership in Rare Disease
Investor Presentation
Q1
FY 2024
Q3
Q2
FY 2023
S-3ASR
Registration Statement for Securities to be Offered to Employees
Notice of Exempt Offering of Securities
Prospectus filed pursuant to Rule 424(b)(5)
Definitive Proxy Statement
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Amended Schedule 13G - Ownership Report